HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study.
about
Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease?Pharmacological prevention of atherothrombotic events in patients with peripheral arterial diseaseGlycaemic control improves perfusion recovery and VEGFR2 protein expression in diabetic mice following experimental PADHbA 1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study.The comparative efficacy of angiosome-directed and indirect revascularisation strategies to aid healing of chronic foot wounds in patients with co-morbid diabetes mellitus and critical limb ischaemia: a literature review.Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps.Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link?Hemoglobin A1c and arterial and ventricular stiffness in older adultsThe prevalence and predictors of an abnormal ankle-brachial index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes.The use of quality improvement and health information technology approaches to improve diabetes outcomes in African American and Hispanic patients.Cardiovascular disease in diabetes: where does glucose fit in?Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty.Cyclophilin A is associated with peripheral artery disease and chronic kidney disease in geriatrics: The Tianliao Old People (TOP) studyLower ankle-brachial index is associated with poor sleep quality in patients with essential hypertension.The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study.Coordinated Activation of VEGF/VEGFR-2 and PPARδ Pathways by a Multi-Component Chinese Medicine DHI Accelerated Recovery from Peripheral Arterial Disease in Type 2 Diabetic Mice.General and gender characteristics of type 2 diabetes mellitus among the younger and older age groups.Risk-assessment score for screening diabetes mellitus among Omani adults.Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia.Risk factors for peripheral arterial disease among patients with chronic kidney disease.Association of Comorbid and Metabolic Factors with Optimal Control of Type 2 Diabetes MellitusArsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study.Nonadherence and factors affecting adherence of diabetic patients to anti-diabetic medication in Assela General Hospital, Oromia Region, EthiopiaNatriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.HbA₁c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients.Glycaemic status and cardiovascular disease in type 2 diabetes mellitus: re-visiting glycated haemoglobin targets for cardiovascular disease prevention.Traditional and non-traditional risk factors for incident peripheral arterial disease among patients with chronic kidney disease.Favorable effects of insulin sensitizers pertinent to peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trialAdherence to glyburide and metformin and associated factors in type 2 diabetes in isfahan, iran.Impact of glycemic control on capsular polysaccharide biosynthesis and opsonophagocytosis of Klebsiella pneumoniae: Implications for invasive syndrome in patients with diabetes mellitus.HbA1c and lower-extremity amputation risk in low-income patients with diabetes.Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment.A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesis.Characteristics of peripheral arterial disease and its relevance to the diabetic population.Diagnosis and assessment of peripheral arterial disease in the diabetic foot.HbA1c and Lower Extremity Amputation Risk in Patients With Diabetes: A Meta-Analysis.Building a Critical Limb Ischemia Program.Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS)High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization.
P2860
Q26852616-742B7114-90CF-48A6-ACCB-9AE776E54B02Q28220999-F00B7A4F-36F1-4BB9-A57A-078CC357E160Q30407641-27FDF77F-2001-487A-B0AC-33059C69BE89Q33766515-13A18C81-F0B7-45D0-BBE8-A927C26A202EQ33851145-CD648282-5E7D-43A3-891D-08EEA67ED55AQ33879565-D190556A-3768-44B8-A708-94FC36B0440EQ34068407-53F0D3CA-B10C-43EF-A6A0-DF7E8EE6A664Q34464672-7AFE91C5-D439-4AB3-B10A-C67E4782B389Q34507270-67059286-8AB9-46ED-BDF3-FF7298406CB4Q34625055-F934AA2B-A9F2-4AC4-9755-DF924D35C832Q35131164-31F58DBF-CA11-43F5-98BD-101E1D945D66Q35137148-68F27866-B4F8-4E1D-A87E-529F84F77867Q35469793-EEE36249-4D16-4451-9834-C7C84AF4D1B4Q35535488-274B57D3-4F32-4AF8-AB5C-481A20E9E075Q35659466-2E763FC1-9CF6-4DCB-A13B-80756BCDBE60Q35896110-9B68C243-C5DD-485E-A5BE-5ACB64899DB1Q36216091-71A1E602-EE3D-4BEB-89A6-84946F5A86BFQ36321269-503FC4AE-1846-43E9-8896-4B962824B07AQ36394939-D14B7690-7C0C-4C8E-BDBB-EFFCB31B69E9Q36633005-72E998C9-CB54-4AB3-841B-B45E45DCE272Q36652294-8463439A-B7A9-49FF-9F90-46E25808B712Q36667608-99DDA0AA-3966-4276-8A5B-A064FED977D9Q36764977-04BF17A2-3532-4C6F-9296-1ED025E16B35Q36801347-FAEAF5F6-BB93-48C0-BF2B-689B24C2F383Q36820589-6BEF6452-2CD4-4DA3-8129-A5E86AEF83D1Q36922083-7B216959-35F4-4965-B853-7521B4B7C1FAQ36966069-3BCE4DF9-17CC-41DB-B845-C0EB37D0EE88Q37028901-FD7B171D-4DBB-4667-BE29-19436CDF4D0EQ37193704-43C728B1-58FE-4D76-A23E-8CD291C6FD16Q37268117-A78F3C4A-5E81-44AC-BA05-3E8230038F61Q37268462-04581105-2434-4027-8955-C49994BD2F84Q37278058-017F0625-F75B-4070-BC2B-FF8BBC1B8903Q37321632-3AFAC09A-714E-4C4B-A978-9E7A953BDD98Q37510205-4D243990-5BE1-4E46-97FE-C93ABFDDD5DEQ37920503-9E84C29D-FCF0-4B3D-89AA-A77AB1463B83Q38375455-AE8513F2-3230-4C9B-AAA6-63B4DAD46F35Q38541241-EBA4BA32-7766-4E30-A18E-E17270080DAEQ38862389-F13D88A3-1B55-412B-BF11-5A26B8049B0AQ39205827-589D598C-FE94-4F3C-8B97-5E064F111316Q40069042-25EF9E2E-A2EC-44DA-937E-400B315BC91E
P2860
HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
HbA1c and peripheral arterial ...... sis Risk in Communities study.
@ast
HbA1c and peripheral arterial ...... sis Risk in Communities study.
@en
HbA1c and peripheral arterial ...... sis Risk in Communities study.
@nl
type
label
HbA1c and peripheral arterial ...... sis Risk in Communities study.
@ast
HbA1c and peripheral arterial ...... sis Risk in Communities study.
@en
HbA1c and peripheral arterial ...... sis Risk in Communities study.
@nl
prefLabel
HbA1c and peripheral arterial ...... sis Risk in Communities study.
@ast
HbA1c and peripheral arterial ...... sis Risk in Communities study.
@en
HbA1c and peripheral arterial ...... sis Risk in Communities study.
@nl
P2093
P1433
P1476
HbA1c and peripheral arterial ...... sis Risk in Communities study.
@en
P2093
A Richey Sharrett
Keattiyoat Wattanakit
Michael W Steffes
P304
P356
10.2337/DIACARE.29.04.06.DC05-2018
P407
P577
2006-04-01T00:00:00Z